Acute Asthma Exacerbation: Emergency Referral Criteria and Management
Immediate Emergency Department Referral – Red Flags
Any patient presenting with life-threatening features requires immediate emergency department transfer without delay. 1
Life-Threatening Features Requiring Immediate ED Referral:
- Peak expiratory flow (PEF) <33% of predicted or personal best 1, 2
- Silent chest, cyanosis, or feeble respiratory effort 1, 3
- Altered mental status (confusion, drowsiness, exhaustion, or coma) 1, 3
- Bradycardia or hypotension 1, 3
- Normal or elevated PaCO₂ ≥42 mmHg in a breathless patient (indicates impending respiratory failure) 1, 2, 3
- Severe hypoxia: PaO₂ <8 kPa (60 mmHg) despite oxygen therapy 1, 2
- Prior intubation or ICU admission for asthma (high-risk patient requiring lower threshold for admission) 3
Severe Exacerbation Features Requiring ED Referral:
Immediate hospital referral is required when any of the following persist after initial outpatient treatment: 1
- Inability to speak full sentences in one breath 1, 2
- Respiratory rate >25 breaths/min 1, 2
- Heart rate >110 beats/min 1, 2
- PEF <50% of predicted or personal best 1, 2
- PEF 15-30 minutes after initial nebulization remains <33% of predicted 1
Lower Threshold for Admission Applies When:
- Presentation in afternoon or evening (rather than morning) 1, 3
- Recent nocturnal symptoms or worsening symptoms 1
- Previous severe attacks, especially with rapid onset 1
- ≥2 hospitalizations or ≥3 ED visits in past year 3
- Recent hospitalization or ED visit within past month 3
- Concern over patient's ability to assess severity 1
- Poor social circumstances or inadequate support 1, 3
Outpatient Management (When Safe to Treat at Home)
Patients may be managed at home only if they can complete sentences, have respiratory rate <25/min, heart rate <110/min, and PEF >50% predicted after initial treatment. 1
Immediate Outpatient Treatment Protocol:
High-dose inhaled β₂-agonist: Salbutamol 5 mg or terbutaline 10 mg via oxygen-driven nebulizer, OR 4-8 puffs via MDI with spacer every 20 minutes for 3 doses 1, 3
Systemic corticosteroids immediately: Prednisolone 30-60 mg orally (do NOT delay while "trying bronchodilators first") 1, 3
Reassess PEF 15-30 minutes after first bronchodilator dose 1, 2
Response-Based Management:
Good Response (PEF >75% predicted):
- Continue usual maintenance therapy 1, 3
- Monitor symptoms and PEF on chart 1
- Follow-up within 48 hours 1, 3
Incomplete Response (PEF 50-75% predicted):
Poor Response (PEF <50% predicted or persistent severe features):
- Arrange immediate hospital admission 1, 3
- Repeat nebulized β-agonist 1
- Add ipratropium 0.5 mg to nebulizer 1
Critical Pitfall to Avoid:
Never underestimate severity based on subjective assessment alone—objective PEF measurement is mandatory, as failure to measure objectively is the most common preventable cause of asthma deaths. 1, 3
Specialist Referral Criteria (After Stabilization)
Mandatory Follow-Up Schedule:
- Primary care follow-up within 1 week of any acute exacerbation 1, 3
- Respiratory specialist clinic within 4 weeks 1, 3
Indications for Respiratory Specialist Referral:
- Any patient requiring hospital admission 1
- Moderate exacerbations requiring systemic corticosteroids (consider referral) 1
- Recurrent exacerbations (≥2 hospitalizations or ≥3 ED visits in past year) 3
- Previous life-threatening attack or ICU admission 1, 3
- Poor symptom control despite treatment escalation 3
Discharge Requirements Before Leaving ED/Clinic:
- PEF ≥70% of predicted or personal best 3
- Stable for 30-60 minutes after last bronchodilator dose 3
- Verify correct inhaler technique 1, 3
- Provide written self-management plan with PEF zones 1, 3
- Supply peak flow meter if patient doesn't have one 3
- Prescribe oral prednisolone 40-60 mg daily for 5-10 days (no taper needed) 3
- Initiate or continue inhaled corticosteroids 3
Absolute Contraindications in Acute Asthma
Never administer sedatives of any kind—this is absolutely contraindicated and potentially fatal. 1, 3